CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lessened its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 0.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 723,032 shares of the company’s stock after selling 1,209 shares during the period. Charles Schwab Investment Management Inc.’s holdings in CRISPR Therapeutics were worth $28,459,000 as of its […]
Charles Schwab Investment Management Inc. lessened its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 0.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 723,032 shares of the company’s stock after selling 1,209 shares during the period. Charles Schwab Investment Management Inc.’s holdings in CRISPR Therapeutics were worth $28,459,000 as of its […]
